Cefuroxime and Mobic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefuroxime (cefuroxime sodium) and Mobic (meloxicam). Common drug interactions include neck mass among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Cefuroxime and Mobic. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.



On Aug, 02, 2026

27 people who take Cefuroxime and Mobic together, and have interactions are studied.

Cefuroxime and Mobic drug interactions.

What are the common drug interactions of Cefuroxime and Mobic, by gender? *:

female:

  1. Neck mass (mass in neck)
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Chronic kidney disease
  4. Renal failure (kidney dysfunction)
  5. Renal injury (kidney injury)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Back pain
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  9. Blood pressure increased
  10. Chest pain

male:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Hemiparesis (weakness on one side of the body)
  4. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  5. Left ventricular dysfunction
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Multiple injuries
  8. Muscular weakness (muscle weakness)
  9. Renal failure (kidney dysfunction)
  10. Acute myocardial infarction (acute heart attack)

What are the common drug interactions of Cefuroxime and Mobic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Back pain
  3. Blood pressure increased
  4. Cardiac disorder
  5. Chest pain
  6. Chronic kidney disease
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Infusion related reaction
  9. Lung infection
  10. Malaise (a feeling of general discomfort or uneasiness)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  5. Atrial tachycardia (rhythm disturbance that arises in the atria)
  6. Balance disorder
  7. Brain stem haemorrhage (bleeding into structures of brain stem)
  8. Cardiac arrest
  9. Cardiac failure
  10. Carotid arteriosclerosis (plaque deposition in artery)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 48.15%
  2. High Blood Pressure: 7 people, 25.93%
  3. Pain: 7 people, 25.93%
  4. Asthma: 6 people, 22.22%
  5. High Blood Cholesterol: 6 people, 22.22%
  6. Nausea (feeling of having an urge to vomit): 4 people, 14.81%
  7. Muscle Spasms (muscle contraction): 4 people, 14.81%
  8. Depression: 4 people, 14.81%
  9. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 14.81%
  10. Cough: 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Cefuroxime and Mobic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefuroxime and Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefuroxime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime sodium and meloxicam (the active ingredients of Cefuroxime and Mobic, respectively), and Cefuroxime and Mobic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: